30Indexed trials
mesh condition
Central Nervous System Diseases
Intelligence
Central Nervous System Diseases intelligence: 30 indexed trials, 8 recruiting studies, 27 sponsors across 36 countries.
8Recruiting
27Sponsors
36Countries
Leading sponsors
Novartis40 recruiting
Beijing Friendship Hospital10 recruiting
Eisai Co., Ltd.10 recruiting
Comenius University11 recruiting
Connecta Therapeutics, S.L.11 recruiting
Danilo Toni10 recruiting
Children's Hospital Medical Center, Cincinnati10 recruiting
Eisai Limited10 recruiting
Elizabeth K Rhodus10 recruiting
Grethe Andersen10 recruiting
Hoffmann-La Roche10 recruiting
Beats Medical10 recruiting
Geographic activity
United States14trials
United Kingdom5trials
Canada5trials
France5trials
Spain4trials
China3trials
Italy3trials
Sweden3trials
South Korea2trials
Romania2trials
Bulgaria2trials
Russia2trials
Leading interventions
CAD1063trials
E20202trials
ACI-24.060 at Dose B in Study Part 1a1trials
ACI-24.060 at Dose C in Study Part 1a1trials
ACI-24.060 at Dose C in Study Part 21trials
ACI-24.060 with an additional adjuvant at Dose D in Study Part 1b1trials
BGG4921trials
ACI-24.060 with an additional adjuvant at Dose E in Study Part 1b1trials
BPN147701trials
ACI-24.060 at Dose B in Study Part 21trials
CTH1201trials
ACI-24.060 at Dose A in Study Part 21trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.